Advisory Services Network’s Achieve Life Sciences ACHV Stock Holding History

Advisory Services Network’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-13,000	Closed	-$111K	–	1400
2021 Q3	$111K	Buy	+13,000	New	+$102K	﹤0.01%	1331
2018 Q4	–	Sell	-25	Closed	-$2K	–	2515
2018 Q3	$2K	Buy	+25	New	+$1.58K	﹤0.01%	2279

Other funds holding ACHV

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Advisory Services Network's ACHV Position: Q4 2021 in Review

Advisory Services Network sold out of Achieve Life Sciences (ACHV) in Q4 2021, closing a stake of 13,000 shares — an estimated $111K sold.

Advisory Services Network first reported a position in ACHV in Q3 2018 and held it in 2 quarters. The position peaked at $111K in Q3 2021. 29 funds tracked by Wall St. Rank hold ACHV as of Q4 2021.

Advisory Services Network reported no remaining Achieve Life Sciences position as of Q4 2021 after selling out during the quarter.
Advisory Services Network sold 13,000 Achieve Life Sciences shares in Q4 2021, an estimated $111K.
Advisory Services Network first reported a position in Achieve Life Sciences in Q3 2018 and held it in 2 quarters.
Advisory Services Network's Achieve Life Sciences position peaked at $111K in Q3 2021.
29 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2021.

Based on Advisory Services Network's 13F filing for Q4 2021, filed 14 Feb 2022.